| Titolo |
Pubblicato in |
Anno |
| Wnt signaling as a translational target in rheumatoid and psoriatic arthritis |
JOURNAL OF TRANSLATIONAL MEDICINE |
2025 |
| Adherence to vaccination against SARS-CoV-2 and vaccine safety in patients with immunoglobulin G4-related disease |
REUMATISMO |
2025 |
| Kidney Biopsy and Immuno-Rheumatological Diseases: A Retrospective and Observational Study |
JOURNAL OF PERSONALIZED MEDICINE |
2024 |
| Comorbidities in the Spondyloarthritis GISEA Cohort: an average treatment effect analysis on patients treated with bDMARDs |
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
2024 |
| Management of patients with inflammatory rheumatic diseases after treatment failure with a first tumour necrosis factor inhibitor. a narrative review |
MODERN RHEUMATOLOGY |
2024 |
| Retention rate of abatacept in rheumatoid arthritis patients in a real-life setting: results from a monocentric cohort |
REUMATISMO |
2024 |
| Clinical, histologic, and immunologic signatures of Small Fiber Neuropathy in Systemic Lupus Erythematosus |
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM |
2024 |
| Antiphospholipid Syndrome: Insights into Molecular Mechanisms and Clinical Manifestations |
JOURNAL OF CLINICAL MEDICINE |
2024 |
| Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus |
AUTOIMMUNITY REVIEWS |
2024 |
| Preferences for diagnostic pathways and treatment choice in systemic lupus erythematosus: a patient-based discrete choice experiment |
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
2024 |
| Diagnostic pathway and treatment preferences for systemic lupus erythematosus: a physician-based discrete choice experiment |
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
2024 |
| Surface antigen serocleared hepatitis B virus infection increases the risk of mixed cryoglobulinemia vasculitis in male patients with chronic hepatitis C |
FRONTIERS IN IMMUNOLOGY |
2024 |
| Validation of Qualisex questionnaire to evaluate sexual dysfunction in women affected by fibromyalgia |
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
2024 |
| Antibody profiles in the mosaic of "seronegative" APS syndrome |
CLINICAL AND EXPERIMENTAL IMMUNOLOGY |
2024 |
| Application of SLE-DAS to assess subcutaneous belimumab efficacy in a cohort of systemic lupus erythematosus patients |
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
2024 |
| Caffeine improves systemic lupus erythematosus endothelial dysfunction by promoting endothelial progenitor cells survival |
RHEUMATOLOGY |
2024 |
| Belimumab 10 years later. how drug positioning has changed |
IMMUNOLOGIC RESEARCH |
2024 |
| Fibromyalgia, mood disorders and chronic damage are the main determinants of worse quality of life in systemic lupus erythematosus patients. results from a cross-sectional analysis. |
LUPUS |
2024 |
| PASSing to the patient side: early achieving of an acceptable symptom state in patients with rheumatoid arthritis treated with Janus kinase inhibitors. |
REUMATISMO |
2024 |
| Early decrease of T-bet+ B cells during subcutaneous belimumab predicts response to therapy in systemic lupus erythematosus patients |
IMMUNOLOGY LETTERS |
2024 |
